These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20023364)

  • 1. The rehabilitation programme of an adult phenylketonuria with upper motor neuron involvement.
    Soyupek F; Koyuncuoglu H; Cindas A; Ilgun E; Tak R
    J Back Musculoskelet Rehabil; 2009; 22(1):49-53. PubMed ID: 20023364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An adult patient with phenylketonuria before and one year after reinstitution of diet therapy].
    Tiefenthaler M; Seidl R; Scheibenreiter S; Wandl-Vergesslich K; Stöckler-Ipsiroglu S
    Wien Klin Wochenschr; 1999 Jan; 111(1):33-6. PubMed ID: 10067268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spasticity and white matter abnormalities in adult phenylketonuria.
    McCombe PA; McLaughlin DB; Chalk JB; Brown NN; McGill JJ; Pender MP
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):359-61. PubMed ID: 1602307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal serum phenylalanine for adult patients with phenylketonuria.
    Okano Y; Nagasaka H
    Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phenylketonuria with adult-onset neurological manifestation].
    Ishimaru K; Tamasawa N; Baba M; Matsunaga M; Takebe K
    Rinsho Shinkeigaku; 1993 Sep; 33(9):961-5. PubMed ID: 8299276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of 'ready-to-drink' protein substitute in phenylketonuria.
    Gokmen-Ozel H; MacDonald A; Daly A; Hall K; Ryder L; Chakrapani A
    J Hum Nutr Diet; 2009 Oct; 22(5):422-7. PubMed ID: 19743980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma thiols and their determinants in phenylketonuria.
    Colomé C; Artuch R; Sierra C; Brandi N; Lambruschini N; Campistol J; Vilaseca MA
    Eur J Clin Nutr; 2003 Aug; 57(8):964-8. PubMed ID: 12879091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spastic hypertonia and movement disorders: pathophysiology, clinical presentation, and quantification.
    Sheean G; McGuire JR
    PM R; 2009 Sep; 1(9):827-33. PubMed ID: 19769916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing dietary practices in phenylketonuria.
    MacDonald A; Gökmen-Ozel H; Daly A
    Turk J Pediatr; 2009; 51(5):409-15. PubMed ID: 20112594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults.
    Moats RA; Moseley KD; Koch R; Nelson M
    Pediatrics; 2003 Dec; 112(6 Pt 2):1575-9. PubMed ID: 14654668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year audit of the hyperphenylalaninaemia/phenylketonuria spectrum in Victoria.
    Boneh A; Francis DE; Humphrey M; Upton HJ; Peters HL
    J Paediatr Child Health; 2006 Sep; 42(9):496-8. PubMed ID: 16925533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
    Trefz FK; Blau N
    Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment.
    Battistini S; De Stefano N; Parlanti S; Federico A
    Funct Neurol; 1991; 6(2):177-80. PubMed ID: 1916459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
    Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
    Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future role of large neutral amino acids in transport of phenylalanine into the brain.
    Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
    Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion.
    Mayer NH
    Muscle Nerve Suppl; 1997; 6():S1-13. PubMed ID: 9826979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
    Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin for the management of adult patients with upper motor neuron syndrome.
    Esquenazi A; Mayer NH; Elia AE; Albanese A
    Toxicon; 2009 Oct; 54(5):634-8. PubMed ID: 19470335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.